These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 4131106)
1. [Histological and ultrastructural study of treated Hodgkin's disease. Preliminary report on the effect of chemotherapy on tumoral nodes]. Widgren S; Alberto P; Bouzakoura C; Gabbiani G; Gould V; Kapanci Y Schweiz Med Wochenschr; 1974 Feb; 104(8):295-7. PubMed ID: 4131106 [No Abstract] [Full Text] [Related]
3. The influence of endolymphatically administered 1311 on the ultrastructural pattern of the lymph nodes in Hodgkin's disease. Vorbrodt A; Skalska-Vorbrodt J; Krzyzowska-Gruca S Ann Med Sect Pol Acad Sci; 1974; 19(2):151-2. PubMed ID: 4454744 [No Abstract] [Full Text] [Related]
4. [Ultrastructural aspects of cells in Hodgkin's lesions]. Mirancea N; Mirancea D Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1987; 39(3):273-9. PubMed ID: 2891176 [No Abstract] [Full Text] [Related]
5. [Clinical evaluation of combined treatment of stage III(B) Hodgkin's disease]. Kanaev SV; Golovanov SG; Girshovich MM; Gershanovich ML Vopr Onkol; 2006; 52(5):525-30. PubMed ID: 17168360 [TBL] [Abstract][Full Text] [Related]
6. Ammoniacal silver staining of lymph node cells. I. its potential value for the diagnosis of Hodgkin's disease. Rengifo E; Quintero S; Marinello Z Neoplasma; 1983; 30(4):469-73. PubMed ID: 6193436 [TBL] [Abstract][Full Text] [Related]
7. Stage I and II Hodgkin's disease: involved-field radiotherapy versus extended-field radiotherapy versus involved-field radiotherapy followed by six cycles of MOPP. Hagemeister FB; Fuller LM; Velasquez WS; Sullivan JA; North L; Butler JJ; Johnston DA; Shullenberger CC Cancer Treat Rep; 1982 Apr; 66(4):789-98. PubMed ID: 7074649 [No Abstract] [Full Text] [Related]
8. Hodgkin's disease: treatment with low dose radiation and chemotherapy. Donaldson SS Front Radiat Ther Oncol; 1981; 16():122-33. PubMed ID: 7333475 [No Abstract] [Full Text] [Related]
9. Ultrastructural study of ribonucleoprotein constituents and chromatin disposition in various cells of Hodgkin's disease. Hernández-Pando R; Vázquez-Nin GH; Zavala G Arch Invest Med (Mex); 1988; 19(2):173-81. PubMed ID: 3228351 [No Abstract] [Full Text] [Related]
10. Cell proliferation in Hodgkin's disease. Peckham MJ; Cooper EH Natl Cancer Inst Monogr; 1973 May; 36():179-89. PubMed ID: 4744576 [No Abstract] [Full Text] [Related]
11. [Is irradiation of intact ileoinguinal lymph nodes necessary in radiochemotherapy for stage-III Hodgkin's disease?]. Kanaev SV; Girshovich MM; Golovanov SG; Gershanovich ML Vopr Onkol; 2007; 53(4):453-5. PubMed ID: 17969410 [TBL] [Abstract][Full Text] [Related]
12. Quantitative ultrastructural analysis of in vivo lymphocyte-Reed-Sternberg cell interactions in Hodgkin's disease. Archibald RB; Frenster JH Natl Cancer Inst Monogr; 1973 May; 36():239-45. PubMed ID: 4542772 [No Abstract] [Full Text] [Related]
13. [Unusual symptomatology of Hodgkin's disease: massive invasion of the blood by abnormal cells]. Thuot C; Gariépy G; Monté M; Perron L Union Med Can; 1973 Aug; 103(8):1675-8. PubMed ID: 4134827 [No Abstract] [Full Text] [Related]
14. [Fibrosis of peritoneal lymph nodes in Hodgkin's disease without lymphographic presentation: a possible symptom]. Magnus L; Göbbeler T; Heissen E Dtsch Med Wochenschr; 1968 Oct; 93(42):1999+. PubMed ID: 5678865 [No Abstract] [Full Text] [Related]
15. Hodgkins disease: the relationship of histology and staging to treatment and prognosis. French TJ; Ross M Cent Afr J Med; 1976 Sep; 22(9):169-73. PubMed ID: 975230 [No Abstract] [Full Text] [Related]
16. [Developments and problems in the diagnosis and treatment of patients with Hodgkin's disease]. Haanen C Ned Tijdschr Geneeskd; 1983 Feb; 127(6):252-6. PubMed ID: 6828192 [No Abstract] [Full Text] [Related]